Pharmaceutical

Rona Therapeutics gains Series A+ funds for siRNA pipeline expansion

Rona Therapeutics has secured $35m in its Series A+ financing round to advance its metabolic siRNA pipeline in clinical settings.

Jul 20, 2024 - 04:00
Rona Therapeutics gains Series A+ funds for siRNA pipeline expansion
Rona Therapeutics has secured $35m in its Series A+ financing round to advance its metabolic siRNA pipeline in clinical settings.
Read the original article

Tags:

Previous Article

Seventh patient ‘cured’ of HIV among highlights at AIDS 2024

Next Article

Meitheal gains rights to CONTEPO from Nabriva in North America

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Epic and Microsoft’s AI collaboration, Amazon and 3M, & Abbott’s CGM momentum

STAT+: Epic and Microsoft’s AI collaboration, Amazon an...

Apr 23, 2023

STAT+: Why Novartis is changing the name of its research labs

STAT+: Why Novartis is changing the name of its researc...

Sep 8, 2023

Sandoz unveils biosimilar Hyrimoz HCF in Europe

Sandoz unveils biosimilar Hyrimoz HCF in Europe

Nov 22, 2023